Health Care & Life Sciences » Pharmaceuticals | Star Pharmaceutical Ltd.

Star Pharmaceutical Ltd. | Balance Sheet

Fiscal year is January-December. All values SGD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
7,622.00
12,031.20
11,683.90
15,938.60
14,152.30
17,285.40
Total Accounts Receivable
893.10
702.70
2,119.10
674.00
2,240.40
7,115.30
Inventories
3,163.40
7,631.70
4,301.40
4,820.40
5,694.50
10,922.10
Other Current Assets
549.10
3,417.60
1,762.20
373.20
936.80
404.80
Total Current Assets
12,227.70
23,783.20
19,866.70
21,806.10
23,024.00
35,727.60
Net Property, Plant & Equipment
11,572.40
11,140.80
11,894.50
11,226.40
8,726.20
8,428.50
Total Investments and Advances
637.20
603.40
566.90
4,797.00
2,522.80
2,303.10
Intangible Assets
1,401.50
1,728.40
1,338.80
1,273.90
1,190.50
1,369.40
Other Assets
6,386.30
1,705.50
4,949.40
447.80
2,849.90
5,093.70
Total Assets
32,639.20
39,300.60
38,904.30
39,804.90
39,294.30
54,167.80
ST Debt & Current Portion LT Debt
-
-
-
2,494.60
-
Accounts Payable
1,177.70
4,149.20
2,077.60
1,800.90
1,939.50
Income Tax Payable
343.10
302.70
368.10
391.70
-
Other Current Liabilities
3,710.10
3,359.10
2,950.40
2,745.80
9,709.40
Total Current Liabilities
5,230.90
7,810.90
5,396.20
7,432.90
11,649.00
Long-Term Debt
45.90
-
-
-
-
Deferred Taxes
356.00
296.70
261.50
244.90
981.00
Other Liabilities
6,902.50
-
-
-
-
Total Liabilities
12,237.50
7,853.60
5,422.60
7,441.70
11,649.00
Common Equity (Total)
20,303.70
31,447.00
33,481.70
32,363.20
27,645.30
Total Shareholders' Equity
20,303.70
31,447.00
33,481.70
32,363.20
27,645.30
Total Equity
20,401.70
31,447.00
33,481.70
32,363.20
27,645.30
Liabilities & Shareholders' Equity
32,639.20
39,300.60
38,904.30
39,804.90
39,294.30
Accumulated Minority Interest
98.00
-
-
-
-

About Star Pharmaceutical

View Profile
Address
Dalu Town
Qionghai Hainan 571425
China
Employees -
Website http://www.star-pharm.com
Updated 07/08/2019
STAR Pharmaceutical Ltd. is an investment holding company, which engages in the development, manufacture, and trading of pharmaceutical products. The firm focuses on prescription drugs in the field of antibiotics, cardiovascular drugs, and cerebrovascular medicine. The company was founded on January 10, 2005 and is headquartered in Qionghai, China.